PMC:7247521 / 22-917
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3 | 199-207 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 5 | 334-343 | Species | denotes | 2019-nCov | Tax:2697049 |
| 7 | 406-414 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 33 | 841-855 | Gene | denotes | oxidoreductase | Gene:8630 |
| 35 | 789-792 | Chemical | denotes | FUs | |
| 36 | 866-871 | Chemical | denotes | lipid | MESH:D008055 |
| 39 | 522-530 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 49-54 | NCBITaxon:10239 | denotes | viral |
| T3 | 87-96 | GO:0008152 | denotes | metabolic |
| T4 | 199-207 | SP_7 | denotes | COVID-19 |
| T5 | 217-222 | NCBITaxon:10239 | denotes | viral |
| T6 | 228-241 | CHEBI:67079;CHEBI:67079 | denotes | -inflammatory |
| T7 | 246-255 | GO:0008152 | denotes | metabolic |
| T8 | 334-343 | SP_7 | denotes | 2019-nCov |
| T9 | 406-414 | SP_7 | denotes | COVID-19 |
| T16 | 522-530 | SP_7 | denotes | COVID-19 |
| T17 | 561-570 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T18 | 866-871 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | lipid |
| T19 | 872-889 | GO:0006629 | denotes | metabolic process |
| T25522 | 49-54 | NCBITaxon:10239 | denotes | viral |
| T26726 | 87-96 | GO:0008152 | denotes | metabolic |
| T22563 | 199-207 | SP_7 | denotes | COVID-19 |
| T45473 | 217-222 | NCBITaxon:10239 | denotes | viral |
| T92290 | 228-241 | CHEBI:67079;CHEBI:67079 | denotes | -inflammatory |
| T26450 | 246-255 | GO:0008152 | denotes | metabolic |
| T9512 | 334-343 | SP_7 | denotes | 2019-nCov |
| T7610 | 406-414 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 866-871 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T2 | 6-12 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
| T3 | 199-207 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 406-414 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 522-530 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 74-82 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T2 | 144-145 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T3 | 458-459 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T4 | 492-495 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T5 | 554-560 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
| T6 | 856-864 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 734-742 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T2 | 866-871 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 856-889 | http://purl.obolibrary.org/obo/GO_0045834 | denotes | activity, lipid metabolic process |
| T2 | 866-889 | http://purl.obolibrary.org/obo/GO_0006629 | denotes | lipid metabolic process |
| T3 | 872-889 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolic process |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 110-128 | Sentence | denotes | Graphical abstract |
| T3 | 130-140 | Sentence | denotes | Highlights |
| T4 | 141-183 | Sentence | denotes | • A novel FUNP analysis on QFPD function. |
| T5 | 184-268 | Sentence | denotes | • QFPD act on COVID-19 via anti-viral, anti-inflammatory and metabolic programming. |
| T6 | 269-344 | Sentence | denotes | • 9 QFPD ingredients presented good molecular docking score for 2019-nCov. |
| T7 | 345-415 | Sentence | denotes | • SGMH, MXSG and Others are the top 3 efficient formula for COVID-19. |
| T8 | 417-425 | Sentence | denotes | Abstract |
| T9 | 426-540 | Sentence | denotes | Qingfei Paidu decoction (QFPD), a multi-component herbal formula, has been widely used to treat COVID-19 in China. |
| T10 | 541-614 | Sentence | denotes | However, its active compounds and mechanisms of action are still unknown. |
| T11 | 615-743 | Sentence | denotes | Firstly, we divided QFPD into five functional units (FUs) according to the compatibility theory of traditional Chinese medicine. |